Observational studyEthnicity & disease2025

B-Cell-Targeted Therapies for Black vs White Americans with Relapsing Multiple Sclerosis.

Romae Hylton-Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.